A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
Seagen Inc.
Seagen Inc.
Aileron Therapeutics, Inc.
Daiichi Sankyo
Affimed GmbH
Dizal Pharmaceuticals
SecuraBio
Affimed GmbH
BeiGene
Takeda
HUYABIO International, LLC.
AstraZeneca
Kura Oncology, Inc.
Seagen Inc.
Pfizer
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Solasia Pharma K.K.
Seagen Inc.
Asana BioSciences
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
Eisai Inc.
Eisai Inc.
Celgene
Rhizen Pharmaceuticals SA
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Mundipharma (China) Pharmaceutical Co. Ltd
Celgene
Eisai Inc.
Takeda
Valerio Therapeutics
Pharmacyclics LLC.
Kyowa Kirin Co., Ltd.